More Americans are reporting medication errors; Public Citizen urges lawmakers to oppose off-label bills; BMS launches new I-O campaign
It's the third year of consecutive growth for spending on accredited CME, according to the Accreditation Council for Continuing Medical Education.
The FDA approves J&J psoriasis drug; PARP inhibitors are not cost-effective, ICER says; Verily releases mosquitoes to combat Zika
AstraZeneca CEO reportedly moving to Teva; the FDA reverses on approval for Amicus drug; Merck names winners of Alexa challenge
The drugmaker is one step closer to a potential approval of its experimental cancer treatment.
Former sales reps for Insys plead guilty to kickback allegations; digital health funding on the rise; PhRMA launches campaign about drug costs
How Huge and the New York Civil Liberties Union used lawmakers' own antiquated ideas to support the Reproductive Health Act.
Trump administration considers outcomes-based approach to lower drug prices; Sanofi to acquire vaccines biotech; Nestle partners with Enterome to develop microbiome-based diagnostics
Find out who made award-winning work this year.
When you've figured out the difference, people will walk through fire for you, a mentor once told her.
The relative dearth of Pharma entries, and the fact that Lions Health is very much a separate affair to the rest of the week are two factors for the Lions to keep an eye on.
Gottlieb calls for new opioid training for docs; FDA committee to examine Novartis' CAR-T therapy; no Viagra ads expected during NFL season
The genomics brand brings together 29 descendants of the founding fathers for an atypical July Fourth campaign.
Drug ads on mobile are not providing enough risk info; rare-disease drugmakers are concerned about healthcare bill; volume of opioid prescriptions drops
The acquisition is meant to add creative expertise to the medical communications group.
The FDA suspends three Keytruda studies; drug and device makers gave $8 billion in payments to providers in 2016; Opdivo beat Yervoy in skin-cancer trial
TCG generated revenues of $29.6 million in 2016.
Amgen and Teva raise prices of leukemia drugs twice this year; Roche acquires diabetes app; docs use Snapchat to share patient scans
Here are nine agencies that are gaining traction in healthcare marketing.
Discover how M&A activity in 2016 and 2017 has reshaped North American healthcare agencies and the holding companies that own them.
Here you'll find the last four years of the MM&M Agency Issue.
Healthcare networks instigated a broad set of changes in a grand embrace of non-pharma business that diversified revenue streams and took specialist agencies out of their comfort zones.
Havas Health & You, WPP Health & Wellness, and Klick Health reported the highest revenue last year.
The CEOs of the industry's largest holding companies discuss how they're reasserting their businesses.
Read on for more about the top performing firms, the trends shaping the business, and the story behind each of the top 100 agencies.
The FDA plans to review orphan drug backlog; drugmaker supported charity helped patients pay for donor's drugs; low dose Xarelto gets Priority Review
Walgreens ends merger with Rite Aid; Biogen hires former Novartis exec as SVP of corporate affairs; FDA takes new measures to drive drug pricing competition
Alison Lewis, the global chief marketing officer of Johnson & Johnson consumer division, has little appetite for new flavours and variants but instead wants to rethink innovation as a means to solve consumer problems.
Lawmakers delay healthcare bill vote; Merck affected by cyberattack; more young people are having strokes
Merck's CETP inhibitor anacetrapib and Novartis' monoclonal antibody ACZ885 hit their primary goals in late-stage cardiovascular outcomes trials, both unexpectedly positive results that are heating up this category.
Here you'll find everything from the Patient Journey 2017 supplement to our June issue.
Here you'll find everything from our June 2017 issue, including our Pharma Report, our Hall of Femme, and two roundtable discussions on media and oncology.
The video is part of Pfizer's ongoing corporate ad campaign Before it Became a Medicine.
Merck announces positive trial results for CETP inhibitor; Purdue Pharma defends withholding of OxyContin marketing material; Roche's experimental haemophilia drug significantly cuts bleed rate
The agency founded by Olivier Zitoun in 1999 has been snapped up as part of LiquidHub's push to offer multi-disciplinary capabilities.
Opdivo's marketing campaigns need to both market to and educate consumers about the new immunotherapy cancer treatment.
The performance of generic drugs is not always guaranteed; the FDA approves a new blood thinner; Gottlieb wants rejection letters public
Zaritsky succeeds Jay Bolling, who becomes executive chairman
Novartis drug prevents heart attacks and strokes, per trial; Senate lawmakers unveil healthcare bill; Pfizer receives CRL for Epogen biosimilar
The FDA plans public meeting to encourage generic competition; Mylan reportedly offered rebates to six Medicaid programs; Republicans to present draft bill for Obamacare replacement
The FDA recently proposed studies designed to determine how disclosures in drug ads affect how viewers frame information.
Insurance companies balk at expensive PCSK9 inhibitors; Publicis to focus investments on AI platform; clinical trial reveals Novartis' eye drug requires less frequent injections
How Zicam proved that there is a better, more data-driven approach to buying and measuring TV advertising..
In only four months, Allergan's unbranded Facebook page for Botox has garnered 32 million brand impressions and 12,000 likes.
The FCB Health network won big this year with several campaigns, including work featuring a bra that detects breast cancer and an awareness campaign for human trafficking.
Novartis reports positive Phase-III results for Eylea competitor; AZ faces "critical transition point" in MYSTIC trial; physician shortage expected to rise
Drugmakers are increasingly facing blame from regulators, lawmakers, and the public as the list of lawsuits and investigations at the state and local levels grows.
Under siege from intense competition and the rise of value-based contracts, diabetes drugmakers look to outcomes data to stand out.
Adamis receives FDA approval for EpiPen rival Symjepi; Clovis reports positive trial results for ovarian cancer drug Rubraca; hedge fund billionaire John Paulson joins Valeant board of directors
There's much for marketers to glean from stepping into different environments, working with new partners, and putting assets to work in new ways, said one speaker.
If there is one thing to take away from the opening day at the Cannes Lions International Festival of Creativity, it is this. Find the talks that inspire you, and then find the places with AC.
An Australian road safety campaign caught the eyes of the judges.
A public health campaign developed by McCann Health India for children in Afghanistan was the big winner in 2017.
The jury said the year's best work in the category was a public-health campaign.
In the Lions Health pharma shortlist, released Saturday morning, five branded campaign made it through the judging process for the branded prescription categories.
Apple reportedly working to bring EMRs to iPhone; FDA to study disclosures in ads; Trump admin discussing drug price EO
Google invests in European biotechs; hospitals that restrict sales-rep visits more likely to prescribe cheaper generics; AI could help doctors with new research
The association also recommended that the Centers for Medicare and Medicaid Services negotiate drug prices.
The FDA-approved app will allow MS patients to share their medication injection history with HCPs.
Consent forms and reimbursement are the main deterrents of offering the service.
Sanofi to boost investment in biologics R&D; Sage's awareness campaign criticized; PatientsLikeMe poll finds 95% of patients want some costs of drugs covered
Alkermes lobbies lawmakers on its opioid addiction drug; rep salaries rise; SCOTUS rules in favor of Sandoz in biosimilar suit
In apportioning their media budgets, pharma companies continue to straddle the line between new and traditional strategies.
Teva gets FDA approval for Truvada generic; the FDA rejects Coherus' Neulasta biosimilar; only 17% of Americans find health industries to be innovative
It's never been easy for pharmaceutical companies or healthcare brands to authentically engage with patients or with doctors.
The CEO of FCB Health shares her gelato secrets and talks about why this year is truly the year of healthcare.
He buys macarons to make friends and finds that Cannes is an "extraordinary opportunity to rewire your brain."
Words of the wise: Vacant the Gutter Bar by 2 a.m., and make sure to bring flip flops and go walk on the beach.
The drugmaker has been handed a "public reprimand" by the U.K.'s Prescription Medicines Code of Practice Authority after the creative director of an unnamed agency used the company's patient support materials on its website.
The FDA asks Endo to take opioid off the market; Lilly partners with Swiss biotech; House committee advances PDUFA bill — without off-label provision
Executives discussed the challenges and opportunities they have faced as women.
Novartis CAR-T drug boasts competitive response rates; WPP reports slowing sales for healthcare business; AZ sells migraine drug
The opportunity to reach the millennial audience is great, and there's a lot that brands can do now to ensure that companies stay relevant to Gen Y cultural trends.
Pfizer receives breakthrough designation for experimental rare disease drug; Endocyte cuts 30 jobs; AbbVie RA drug meets Phase-III goals
The bill, introduced in March, is being considered as an amendment in the upcoming PDUFA reauthorization legislation.
The genetics testing company helps Gru find his lost-lost brother in six-week marketing push.
With physicians spending nearly four hours a day on their electronic health records, experts say voice assistants could help reduce their workload one day.
Pfizer increased drug prices by 20% in 2017; Perrigo CEO to retire; MannKind sponsors reality TV show to promote Afrezza
They are asking the American Medical Association to support the policy proposal.
Notably, data for AstraZeneca's Lynparza, Johnson & Johnson's Zytiga, and Loxo Oncology's larotrectinib highlights the move toward specialized medicine.
Medicare beneficiaries struggle to pay for COPD inhalers; Novartis partners with IBM Watson Health; Mylan hasn't lowered EpiPen prices
Putting aside the hype around combination immunotherapies, concerns remain about overall response rates for these drugs.
The executive director of oncology marketing is fascinated by the resilience of the human body.
Oncologists more likely to prescribe drugs when receiving travel, meal payments; Tesaro reportedly considering a sale; AbbVie has best pharma reputation
Industry leaders discussed why a social-centric approach is especially important in oncology, particularly as it relates to health systems, interactions with healthcare providers, and family support.
50% of consumers say they will share their health data with tech giants; pharma CEOs expect pricing proposal from Trump administration; FDA approves generic versions of Strattera
This includes concerns about the effectiveness — and cost-effectiveness — of drugs like Merck's Keytruda and Bristol-Myers Squibb's Opdivo, in combination or alone.
BMS partners on Opdivo combo; one-quarter of insurers have signed an outcomes-based contract with a drugmaker; rebates do not lead to savings for Medicare beneficiaries
The deal highlights ongoing interest in the influential point-of-care market.
Harvard Pilgrim signs two outcomes contracts with AstraZeneca; lobbyists fight over drug-pricing proposals; docs say no to adult ADHD screening test
The tone has changed dramatically since last year for LGBT rights groups, which are now as focused on opposing the Trump administration's policies as celebrating progress and community.
Find data on patent expirations, new drug approvals, top therapeutic classes, and top-selling drugs.
Drug prices, as you may have heard, are kind of high. But price growth has slowed after sharp spikes in 2014 and 2015.
FDA presents ideas to tackle drug prices; patients aware of side effects more likely to report them; scientists use Apple's Research Kit for clinical purposes
The company said adult women between the ages of 50 and 70 are most likely to share content on the social media platform.
Fitness trackers do not reliably track calories, docs find; health-tech startups face market uncertainty; FDA adcom votes in favor of Puma breast-cancer drug
Twitter has launched a customizable Direct Message Card that brands can use to promote and share the bots or other customer experiences they've created, while Snapchat and Instagram have launched stories updates.
Keytruda receives first approval based on a genetic feature and not tumor's location; Alexion reps reportedly crossed ethical lines; profits up at insurers
The regulator also took issue with how Orexigen Therapeutics presented the risk information
This includes Sarepta Therapeutics' Exondys 5 and Vertex Pharmaceuticals' Orkambi.